Cover Image

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents /

Bibliographic Details
Corporate Authors: United States. Department of Health and Human Services. Panel on Clinical Practices for the Treatment of HIV Infection (U.S.), Henry J. Kaiser Family Foundation, United States. Public Health Service, Infectious Diseases Society of America
Format: Book
Language:English
Published: McLean, VA : International Medical Pub., 2001.
Subjects:
Anti-HIV Agents > therapeutic use.
Anti-HIV Agents > administration & dosage.
HIV Infections > practice guideline.
HIV Infections > drug therapy.
Adolescent.
Adult.
Table of Contents:
  • Use of testing for plasma HIV RNA levels and CD4 T cell count in guiding decisions for therapy
  • Testing for drug resistance
  • Considerations for patients with establish HIV infection
  • Considerations for initiating therapy in the patient with asymptomatic HIV infection
  • Considerations for discontinuing therapy
  • Adherence to potent antiretroviral therapy
  • Goals of therapy
  • Initiating therapy in the patient with asymptomatic HIV infection
  • Initiating therapy in advanced HIV disease
  • HAART-associated adverse clinical events
  • Interruption of antiretroviral therapy
  • Considerations for changing a failing regimen
  • Criteria for changing therapy
  • Therapeutic options whtn changing antiretroviral therapy
  • Acute HIV infection
  • Considerations for antiretroviral therapy in the HIV-infected adolescent
  • Considerations for antiretroviral therapy in the HIV-infected pregnant woman
  • Conclusion
  • References
  • Tables
  • Considerations for antiretroviral therapy in women
  • Hydroxyurea
  • Safety and toxicity of individual antiretroviral agents in pregnancy